REFERENCES
- Ni C, Chiu MW. Psoriasis and comorbidities: Links and risks. Clin Cosmet Investig Dermatol 2014;7: 119–32
- Lebwohl M. Psoriasis. Lancet 2003;361: 1197–204
- Kivelevitch D, Mansouri B, Menter A. Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis. Biologics 2014;8: 169–82
- Kastelan M, Prpić Massari L, Peternel S. The role of perforin mediated cell cytotoxicity in psoriasis. Lijec Vjesn 2010;132: 361–4
- Voskoboinik I, Dunstone MA, Baran K, et al. Perforin: Structure, function and role in human immunopathology. Immunol Rev 2010;235: 35–54
- Thiery J, Keefe D, Boulant S, et al. Perforin pores in the endosomal membrane trigger the release of endocytosed granzymes Bintothecytosol of target cells. Nat Immunol 2011;12: 770–7
- Louden BA, Pearce DJ, Lang W, Feldman SR. A Simplified Psoriasis Ares Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J 2004;10: 7
- Kastelan M, Prpić Massari L, Gruber F, et al. Perforin expression is up-regulated in the epidermis of psoriatic lesions. Br J Dermatol 2004;151: 831–6
- van Diest PJ, van Dam P, Henzen-Logmans SC, et al. A scoring system for immunohistochemical staining: Consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group. J Clin Pathol 1997;50: 801–4
- Blott EJ, Griffiths GM. Secretory lysosomes. Nat Rev Mol Cell Biol 2002;3: 122–31
- Krzewski K, Coligan J. Human NK cell lytic granules and regulation of their exocytosis. Front Immunol 2012;3: 1–16
- Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 2006;6: 940–52
- Praper T, Sonnen A, Viero G, et al. Human perforin employs different avenues to damage membranes. J Biol Chem 2011;286: 2946–55
- Yawalkar N, Schmid S, Braathen LR, et al. Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis. Br J Dermatol 2001;144: 1133–9
- Prpic Massari L, Kastelan M, Laskarin G, et al. Analysis of perforin expression in the peripheral blood and lesions in mild and sever psoriasis. J Dermatol Sci 2007;47: 29–36
- Baker BS, Swain AF, Fry L, et al. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 1984;110: 555–64
- Austin LM, Coven TR, Bhardway N, et al. Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17 (TIA-1)+ CD8+ CD3+ CTLs as determined by phenotypic analysis. J Cutan Pathol 1998;25: 79–88
- Bata-Csorgo Z, Hammemberg C, Voorhees JJ, et al. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 1993;178: 1271–81
- Boss JD, Hagenaars C, Das PK, et al. Predominance of memory T cells (CD4+, CDw29+) over naive T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res 1989;281: 24–30
- Elder JT, Bruce AT, Gudjonsson JE, et al. Molecular dissection of psoriasis: Integrating genetics and biology. J Invest Dermatol 2010;130: 1213–26
- Mills KH. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008;38: 2636–49
- Clark RA, Kupper TS. Misbehaving macrophages in the pathogenesis of psoriasis. J Clin Invest 2006;116: 2084–7
- Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22: 531–62
- Kryczek I, Bruce AT, Gudjonsson JE, et al. Induction of memory IL-17+ T cell trafficking and expansion by IFN-gamma: Mechanism and pathological relevance. J Immunol 2008;181: 4733–41
- Dhabhar FS. Psychological stress and immunoprotection versus immunopathology in the skin. Clin Dermatol 2013;31: 18–30
- Mallbris L, Larsson P, Bergqvist S, et al. Psoriasis phenotype at disease onset: Clinical characterization of 400 adult cases. J Invest Dermatol 2005;124: 499–504
- Nickoloff BJ. Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediated skin disease. Viewpoint. J Cutan Pathol 2001;28: 57–64
- Iordanov MS, Sundholm AJ, Simpson EL, et al. Cell death-induced activation of epidermal growth factor receptor in keratinocytes: Implications for restricting epidermal damage in dermatitis. J Invest Dermatol 2005;125: 134–42